Caplin Point Laboratories Limited

Caplin Point Laboratories Ltd is an India-based pharmaceutical company specializing in the development, manufacturing, and export of a wide range of generic formulations. Founded in 1990 and headquartered in Chennai, India, the company has established robust operations covering Latin America, Francophone Africa, and emerging markets, with an additional footprint extending into regulated markets such as the United States. The company's product portfolio encompasses therapeutic categories including anti-infectives, analgesics, anti-allergics, cardiovascular, and gastrointestinal medicines.

Caplin Point is recognized for its backward-integrated supply chain, embracing in-house R&D, API manufacturing, formulation, and packaging facilities. The company continues to invest in expanding its injectables and specialty business, supported by USFDA, EU-GMP, and other international accreditations for its manufacturing sites. Caplin leverages strong distribution channels, a significant field force presence, and partnerships from hospital tenders to retail chains, reinforcing its position as a preferred supplier of generics in its core geographies.